Innovation has been the name of the game for the diabetes technology sector in 2022. The FDA clearances that have followed are translating, in many cases, to big business. The year had a brisk start.

Concerning’ disparities in access to continuous glucose monitors despite black and south Asian people being more likely to live with condition ...

LIVERPOOL— Many young people, most often from ethnically diverse or socially deprived backgrounds, are missing out on the potential benefits of diabetes technology through poor uptake, despite ...

When Embecta spun out from BD just over a year ago, the newly formed diabetes giant already carried breakthrough designation for an insulin patch pump that would specifically target the Type 2 ...

Why persons with type 1 diabetes and continuous insulin infusion fail to achieve optimal glycemic control was the subject of a recent focus group analysis conducted among 37 adult men and women.

Olympians, including Dutch marathon runner Abdi Nageeye, are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.

Insulet’s announcement of FDA clearance of the Omnipod 5, an automated insulin delivery system, continued the momentum the diabetes tech market experienced this week. The Acton, MA-based company said ...

Insulin pumps and continuous glucose monitors are life-changing tools for many people with diabetes, but these devices can have a downside. The relentless barrage of data and alarms, combined with ...